The Department of Health and Social Care (DHSC) are aware of the ongoing manufacturing issues that have affected the supply of some Hormone Replacement Therapy(HRT) products throughout 2019. Prescribing information regarding HRT equivalence to support local decision making is available through various sources such as the British National Formulary, Summary of Product Characteristics (SPC), The Monthly Index of Medical Specialities (MIMS), and other sources including local Medicines Information Centres.

Clinicians are advised to work closely with community pharmacies to understand local availability of HRT products and to help make decisions about appropriate HRT products  for patients who are affected by the supply issues.